Search
for
Sort by
Research 31–60 of 279
- Single nucleotide polymorphisms associated with elevated alanine aminotransferase in patients receiving asunaprevir plus daclatasvir combination therapy for chronic hepatitis C
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Bullous Lesions at Polyethylene Glycol Interferon-alpha-2a Inoculation Site in a Hepatitis C Virus-infected Subject
- Hepatitis C virus: host, environmental and viral factors promoting spontaneous clearance
- Betulinic acid exerts anti‐hepatitis C virus activity via the suppression of NF‐κB‐ and MAPK‐ERK1/2‐mediated COX‐2 expression
- Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
- Assessment of Dermatological Disorders with Chronic Hepatitis C Virus Infection
- Follow‐up of Adverse Drug Reactions from Peginterferon alfa‐2b—Ribavirin Therapy
- Exacerbation of alopecia areata during pegylated interferon alpha-2b and ribavirin therapy, possibly due to the collapse of hair follicle immune privilege
- Drug-induced postinfantile giant cell hepatitis
- Integrating multi-omics analyses of Nonomuraea dietziae to reveal the role of soybean oil in [(4′-OH)MeLeu]4-CsA overproduction
- Molecular mechanisms of viral oncogenesis in humans
- 5α-Reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- A randomized controlled clinical trial of recombinant interferon α‐2b in the treatment of acute post‐transfusion hepatitis C: A preliminary report
- An epidemic of porphyria cutanea tarda?
- Hepatology highlights
- Syphilis and Beyond: A Comprehensive Analysis of Associated Infections and Comorbidities in a Five-Year Retrospective Study in the United Arab Emirates (2018-2022)
- Quantitation of Hepatitis C Virus RNA
- Liver Cirrhosis and Circadian Rhythm
- Case Report: Diffuse Hypertrichosis in the Course of Hepatitis C Treatment by IFN-<i>α</i> and Ribavirin
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- Cross-sex hormone therapy for gender dysphoria
- Medical Treatment of Hepatocellular Carcinoma: Any Progress?
- Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis
- Irreversible alopecia universalis during treatment with pegylated interferon-ribavirin for chronic hepatitis C virus infection: Case report and published work review
- Platelet‐rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre‐ and post‐treatment evaluation